HBI
52
4
EQT
47
8
AVGO
47
12
DAL
64
2
RRC
63
8
AZO
58
-2
EQIX
63
3
PPL
44
-3
IP
54
-2
HUM
34
-7
ADSK
67
2
LB
9
-3
F
40
-3
PYPL
62
2
JNJ
35
-6
GPC
37
-3
RHI
59
2
SWKS
50
2
BBY
48
2
AVB
57
2
HBI
52
4
EQT
47
8
AVGO
47
12
DAL
64
2
RRC
63
8
AZO
58
-2
EQIX
63
3
PPL
44
-3
IP
54
-2
HUM
34
-7
ADSK
67
2
LB
9
-3
F
40
-3
PYPL
62
2
JNJ
35
-6
GPC
37
-3
RHI
59
2
SWKS
50
2
BBY
48
2
AVB
57
2
Financhill
Back

Avidity Biosciences Vs. Entrada Therapeutics Industry Stock Comparison

Sell
30

RNA
Avidity Biosciences

Last Price:
33.78
Seasonality Move:
53.96%
Buy
64

TRDA
Entrada Therapeutics

Last Price:
18.14
Seasonality Move:
-36.93%
Sell
30
Avidity Biosciences (RNA) is a Sell

Is Avidity Biosciences a Buy, Sell or Hold?

  • The current Avidity Biosciences [RNA] share price is $35.58. The Score for RNA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • RNA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $19.90. The Score for TRDA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RNA Stock Price Chart

What is Avidity Biosciences's stock price today?

  • The Avidity Biosciences share price today is $35.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNA is experiencing selling pressure, which indicates risk of future bearish movement.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $19.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.

RNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.39 Sell
Relative Strength Index (14 RSI): 33.13 Sell
Chaikin Money Flow: -623231 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.44 - 47.22) Sell
Bollinger Bands (100): (41.03 - 46.99) Sell

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.73 Buy
Relative Strength Index (14 RSI): 54.61 Buy
Chaikin Money Flow: -116741 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (18.4 - 20.54) Buy
Bollinger Bands (100): (15.14 - 18.8) Buy

RNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.67 Sell
20-day SMA: 41.77 Sell
50-day SMA: 44.36 Sell
200-day SMA: 36.53 Sell
8-day EMA: 37.84 Sell
20-day EMA: 40.59 Sell
50-day EMA: 42.71 Sell
200-day EMA: 36.35 Sell

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.54 Sell
20-day SMA: 19.46 Buy
50-day SMA: 18.26 Buy
200-day SMA: 15.58 Buy
8-day EMA: 20.37 Sell
20-day EMA: 19.71 Buy
50-day EMA: 18.51 Buy
200-day EMA: 16.37 Buy

Avidity Biosciences Earnings Growth & RNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.27 per share.

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.

Avidity Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):